Cargando…

Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis

Detalles Bibliográficos
Autores principales:	Liu, Qian, Li, Anping, Yu, Shengnan, Qin, Shuang, Han, Na, Pestell, Richard G., Han, Xinwei, Wu, Kongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749251/ https://www.ncbi.nlm.nih.gov/pubmed/36514108 http://dx.doi.org/10.1186/s13045-022-01393-2

Ejemplares similares

DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
por: Liu, Qian, et al.
Publicado: (2018)

CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer
por: Yu, Shengnan, et al.
Publicado: (2020)

DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling
por: Han, Na, et al.
Publicado: (2015)

Endogenous Dach1 in cancer
por: Wu, Kongming, et al.
Publicado: (2015)

DACH1 suppresses breast cancer as a negative regulator of CD44
por: Xu, Hanxiao, et al.
Publicado: (2017)

Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis
por: Yi, Ming, et al.
Publicado: (2020)

The CXCL8-CXCR1/2 pathways in cancer
por: Liu, Qian, et al.
Publicado: (2016)

Recent advances of bispecific antibodies in solid tumors
por: Yu, Shengnan, et al.
Publicado: (2017)

Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
por: Yu, Shengnan, et al.
Publicado: (2017)

DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells
por: Chu, Qian, et al.
Publicado: (2014)

DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling
por: Liu, Yu, et al.
Publicado: (2015)

Simon Dach : Seine freunde und Johann Röling /
Publicado: (1873)

Chimeric antigen receptor T cells: a novel therapy for solid tumors
por: Yu, Shengnan, et al.
Publicado: (2017)

DACH1 inhibits SNAI1-mediated epithelial–mesenchymal transition and represses breast carcinoma metastasis
por: Zhao, F, et al.
Publicado: (2015)

Silencing DACH1 Promotes Esophageal Cancer Growth by Inhibiting TGF-β Signaling
por: Wu, Liang, et al.
Publicado: (2014)

DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3
por: Zhu, Ji, et al.
Publicado: (2016)

Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling
por: Yan, Wenji, et al.
Publicado: (2014)

Role of Dach1 revealed using a novel inner ear-specific Dach1-knockdown mouse model
por: Miwa, Toru, et al.
Publicado: (2019)

Distinct Roles of VEGFA and ANGPT2 in Lung Adenocarcinoma and Squamous Cell Carcinoma
por: Qin, Shuang, et al.
Publicado: (2020)

Small Scale Academic Web Archiving: DACHS
por: Lecher, Hanno E.
Publicado: (2006)

Sterblichkeit der Lungenembolie in der DACH-Region
por: Hobohm, Lukas, et al.
Publicado: (2021)

The clinical significance of CXCL5 in non-small cell lung cancer
por: Wu, Kongju, et al.
Publicado: (2017)

The transcription factor Dach1 is essential for podocyte function
por: Endlich, Nicole, et al.
Publicado: (2018)

DACH1: Its Role as a Classifier of Long Term Good Prognosis in Luminal Breast Cancer
por: Powe, Desmond G., et al.
Publicado: (2014)

DACH1 stimulates shear stress-guided endothelial cell migration and coronary artery growth through the CXCL12–CXCR4 signaling axis
por: Chang, Andrew H., et al.
Publicado: (2017)

Correction: Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
por: Koch, Christian, et al.
Publicado: (2023)

Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
por: Qin, Shuang, et al.
Publicado: (2019)

CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8((3–72))K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis
por: Khan, Muhammad Noman, et al.
Publicado: (2015)

Identification of CXCL13 as an Immune-Related Biomarker Associated with Tumorigenesis and Prognosis in Cutaneous Melanoma Patients
por: Si, Zebing, et al.
Publicado: (2021)

The role of CXCL10 in prognosis of patients with colon cancer and tumor microenvironment remodeling
por: Song, Weiwei, et al.
Publicado: (2021)

Novel lncRNA UPLA1 mediates tumorigenesis and prognosis in lung adenocarcinoma
por: Han, Xiaoyang, et al.
Publicado: (2020)

RDGN-based predictive model for the prognosis of breast cancer
por: Dong, Bing, et al.
Publicado: (2020)

Correction to: Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1
por: Xia, Wenfei, et al.
Publicado: (2020)

Evolution of the Pax-Six-Eya-Dach network: the calcisponge case study
por: Fortunato, Sofia AV, et al.
Publicado: (2014)

Effect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma
por: Zhang, Jiarui, et al.
Publicado: (2018)

Decreased DACH1 expression in glomerulopathy is associated with disease progression and severity
por: Liu, Qing-Quan, et al.
Publicado: (2016)

Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas
por: Gu, Qiang, et al.
Publicado: (2023)

Correction: YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2016)

Correction: Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2023)

Swiss artists-in-labs 2009: Künstler und Wissenschafter unter einem Dach
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8qk39l9q0n7kbfuu5tb1l0nq2c